Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry

Chirality

Volumn 24, Issue 3, 2012, Pages 209-214

  Poggi, Josiane Cristõfani ^a   Da Silva, Flávia Garcez ^a   Coelho, Eduardo Barbosa ^a   Marques, Maria Paula ^a   Bertucci, Carlo ^b   Lanchote, Vera Lucia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

carvedilol; chiral stationary phase; enantiomers; LC MS MS; pharmacokinetics

Indexed keywords

CARVEDILOL;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG BLOOD LEVEL; ENANTIOMER; ENANTIOSELECTIVITY; HUMAN; HYPERTENSION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD CHEMICAL ANALYSIS; CARBAZOLES; CHROMATOGRAPHY, LIQUID; HUMANS; HYPERTENSION; LIMIT OF DETECTION; PROPANOLAMINES; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 84857357858     PISSN: 08990042     EISSN: 1520636X     Source Type: Journal    
DOI: 10.1002/chir.21984     Document Type: Article

References (22)

1. Bartsch W, Sponer G, Strein K, Müller-Beckmann B, Kling L, Böhm E, Martin U, Borbe HO. Pharmacological characteristics of the stereoisomers of carvedilol. Eur J Clin Pharmacol 1990; 38: S104-S107. (Pubitemid 20183992)
2. Chakraborty S, Shukla D, Mishra B, Singh S. Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases. Expert Opin Drug Metab Toxicol 2010; 6: 237-250.
3. Neugebauer G, Akpan W, Kaufmann B, Reiff K. Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound. Eur J Clin Pharmacol 1990; 38: S108-S111. (Pubitemid 20183993)
4. Ishida K, Taira S, Morishita H, Kayano Y, Taguchi M, Hashimoto Y. Stereoselective oxidation and glucuronidation of carvedilol in human liver and intestinal microsomes. Biol Pharm Bull 2008; 31: 1297-1300. (Pubitemid 351871190)
5. Fujimaki M, Murakoshi Y, Hakusui H. Assay and disposition of carvedilol enantiomers in humans and monkeys: evidence of stereoselective presystemic metabolism. J Pharm Sci 1990; 79: 568-572. (Pubitemid 20222718)
6. Giessmann T, Modess C, Hecker U, Zschiesche M, Dazert P, Kunert-Keil C, Warzok R, Engel G, Weitschies W, Cascorbi I, Kroemer HK, Siegmund W. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin Pharmacol Ther 2004; 75: 213-222. (Pubitemid 38314871)
7. Eisenberg EJ, Patterson WR, Kahn GC. High-performance liquid chromatographic method for the simultaneous determination of the enantiomers of carvedilol and its O-desmethyl metabolite in human plasma after chiral derivatization. J Chromatogr 1989; 493: 105-115. (Pubitemid 19216026)
8. Yang E, Wang S, Kratz J, Cyronak MJ. Stereoselective analysis of carvedilol in human plasma using HPLC/MS/MS after chiral derivatization. J Pharm Biomed Anal 2004; 36: 609-615. (Pubitemid 39441333)
9. Spahn H, Henke W, Langguth P, Schloos J, Mutschler E. Measurement of carvedilol enantiomers in human plasma and urine using S-naproxen chloride for chiral derivatization. Arch Pharm (Weinheim) 1990; 323: 465-469. (Pubitemid 20335850)
10. Peccinini RG, Ximenes VF, Cesarino EJ, Lanchote VL. Stereoselective analysis of carvedilol in human plasma and urine using HPLC after chiral derivatization. Biopharm Drug Dispos 2008; 29: 280-288.
11. Wang S, Cyronak M, Yang E. Does a stable isotopically labelled internal standard always correct analysis response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J Pharm Biomed Anal 2007; 43: 701-707. (Pubitemid 46001699)
12. Clohs L, McErlane KM. Comparison between capillary electrophoresis and high-performance liquid chromatography for the stereoselective analysis of carvedilol in serum. J Pharm Biomed Anal 2003; 31: 407-412. (Pubitemid 36254882)
13. Saito M, Kawana J, Ohno T, Kaneko M, Mihara K, Hanada K, Sugita R, Okada N, Oosato S, Nagayama M, Sumiyoshi T, Ogata H. Enantioselective and highly sensitive determination of carvedilol in human plasma and whole blood after administration of the racemate using normal-phase high-performance liquid chromatography. J Chromatogr B Anal Technol Biomed Life Sci 2006; 843: 73-77. (Pubitemid 44512246)
14. Medvedovici A, Albu F, Georgita C, Sora DI, Galaon T, Udrescu S, David V. Achiral-chiral LC/LC-FLD coupling for determination of carvedilol in plasma samples for bioequivalence purposes. J Chromatogr B Anal Technol Biomed Life Sci 2007; 850: 327-335. (Pubitemid 46618178)
15. Clohs L, McErlane KM. Development of a capillary electrophoresis assay for the determination of carvedilol enantiomers in serum using cyclodextrins. J Pharm Biomed Anal 2001; 24: 545-554. (Pubitemid 32119569)
16. Behn F, Michels S, Läer S, Blaschke G. Separation of carvedilol enantiomers in very small volumes of human plasma by capillary electrophoresis with laser-induced fluorescence. J Chromatogr B Biomed Sci Appl 2001; 755: 111-117. (Pubitemid 32324075)
17. Do Carmo Borges NC, Mendes GD, de Oliveira Silva D, Marcondes Rezende V, Barrientos-Astigarraga RE, De Nucci G. Quantification of carvedilol in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to bioequivalence study. J Chromatogr B Anal Technol Biomed Life Sci 2005; 822: 253-262. (Pubitemid 40994059)
18. Jeong DW, Kim YH, Ji HY, Youn YS, Lee KC, Lee HS. Analysis of carvedilol in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal 2007; 44: 547-552. (Pubitemid 46887635)
19. Li S, Liu G, Jia J, Liu Y, Pan C, Yu C, Cai Y, Ren J. Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 2007; 847: 174-181. (Pubitemid 46331021)
20. Food and Drug Administration, Center for Drug Evaluation and Research (May 2001). Available at:. Accessed on March 6, 2009.
21. Brazilian Society of Cardiology, Brazilian Society of Hypertension, Brazilian Society of Nephrology. V Brazilian Guidelines for Arterial Hypertension 2006. Int J Atheroscler 2006; 1: 71-123.
22. Packer M, Lukas MA, Tenero DM, Baidoo CA, Greenberg BH,; 369 Study Group. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction. Am J Cardiol 2006; 98: 39L-45L.